Patients with tumors of wild-type VHL were associated with nodal involvement (p = 0.019) and showed worse DSS compared with those with ccRCC carrying one or two VHL inactivating events (33 months vs. 107 months, p = 0.016). This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.